

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 7.79871858 |
| 2 | protein neddylation (GO:0045116) | 7.34101223 |
| 3 | regulation of platelet activation (GO:0010543) | 6.10542408 |
| 4 | regulation of platelet aggregation (GO:0090330) | 6.04867695 |
| 5 | protein retention in ER lumen (GO:0006621) | 5.76453522 |
| 6 | sequestering of extracellular ligand from receptor (GO:0035581) | 5.74432143 |
| 7 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.65849766 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.54576747 |
| 9 | wound healing, spreading of epidermal cells (GO:0035313) | 5.48451023 |
| 10 | blood coagulation, intrinsic pathway (GO:0007597) | 5.18833094 |
| 11 | wound healing, spreading of cells (GO:0044319) | 5.17977064 |
| 12 | peptidyl-proline hydroxylation (GO:0019511) | 5.16515259 |
| 13 | type B pancreatic cell proliferation (GO:0044342) | 5.15865560 |
| 14 | COPI coating of Golgi vesicle (GO:0048205) | 5.11483586 |
| 15 | Golgi transport vesicle coating (GO:0048200) | 5.11483586 |
| 16 | adenosine receptor signaling pathway (GO:0001973) | 5.09209924 |
| 17 | positive regulation of mast cell activation (GO:0033005) | 5.08513943 |
| 18 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.97762227 |
| 19 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.96084254 |
| 20 | negative regulation of platelet activation (GO:0010544) | 4.87510782 |
| 21 | fibril organization (GO:0097435) | 4.83323065 |
| 22 | angiogenesis involved in wound healing (GO:0060055) | 4.78699040 |
| 23 | protein targeting to plasma membrane (GO:0072661) | 4.78038741 |
| 24 | positive regulation of actin filament depolymerization (GO:0030836) | 4.73232047 |
| 25 | neutrophil activation (GO:0042119) | 4.63626352 |
| 26 | lipoxygenase pathway (GO:0019372) | 4.59158489 |
| 27 | positive regulation of osteoblast proliferation (GO:0033690) | 4.55243583 |
| 28 | regulation of integrin activation (GO:0033623) | 4.51330448 |
| 29 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.50461035 |
| 30 | negative regulation of norepinephrine secretion (GO:0010700) | 4.47658091 |
| 31 | low-density lipoprotein particle remodeling (GO:0034374) | 4.45505965 |
| 32 | membrane raft organization (GO:0031579) | 4.44799147 |
| 33 | actin filament depolymerization (GO:0030042) | 4.42023805 |
| 34 | negative regulation of heart rate (GO:0010459) | 4.40621677 |
| 35 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.40212692 |
| 36 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.33133342 |
| 37 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.30321577 |
| 38 | regulation of tight junction assembly (GO:2000810) | 4.25575372 |
| 39 | granulocyte activation (GO:0036230) | 4.16107082 |
| 40 | regulation of macrophage cytokine production (GO:0010935) | 4.16068170 |
| 41 | low-density lipoprotein particle clearance (GO:0034383) | 4.14588900 |
| 42 | platelet aggregation (GO:0070527) | 4.11565444 |
| 43 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.08592903 |
| 44 | response to laminar fluid shear stress (GO:0034616) | 4.06680252 |
| 45 | protein hydroxylation (GO:0018126) | 4.06643929 |
| 46 | regulation of metalloenzyme activity (GO:0048552) | 4.05894137 |
| 47 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 4.04633632 |
| 48 | vascular smooth muscle contraction (GO:0014829) | 4.01140589 |
| 49 | extracellular fibril organization (GO:0043206) | 3.96372786 |
| 50 | cranial suture morphogenesis (GO:0060363) | 3.94795591 |
| 51 | cellular response to arsenic-containing substance (GO:0071243) | 3.94420800 |
| 52 | positive regulation of macrophage differentiation (GO:0045651) | 3.93771885 |
| 53 | regulation of lipoprotein metabolic process (GO:0050746) | 3.88823860 |
| 54 | 4-hydroxyproline metabolic process (GO:0019471) | 3.88211978 |
| 55 | cell adhesion mediated by integrin (GO:0033627) | 3.87390865 |
| 56 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.86992345 |
| 57 | myeloid cell homeostasis (GO:0002262) | 3.80562348 |
| 58 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.78662044 |
| 59 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.78131669 |
| 60 | apoptotic cell clearance (GO:0043277) | 3.77410813 |
| 61 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.76048073 |
| 62 | platelet formation (GO:0030220) | 3.73281091 |
| 63 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.73223748 |
| 64 | positive regulation of receptor recycling (GO:0001921) | 3.73103205 |
| 65 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.73016957 |
| 66 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.70311320 |
| 67 | megakaryocyte development (GO:0035855) | 3.70270346 |
| 68 | negative regulation of appetite (GO:0032099) | 3.69110272 |
| 69 | negative regulation of response to food (GO:0032096) | 3.69110272 |
| 70 | negative regulation of protein localization to cell surface (GO:2000009) | 3.68006307 |
| 71 | polyamine biosynthetic process (GO:0006596) | 3.62775948 |
| 72 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.61571333 |
| 73 | * platelet activation (GO:0030168) | 3.58464007 |
| 74 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.58015267 |
| 75 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.57075633 |
| 76 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.56473003 |
| 77 | dermatan sulfate biosynthetic process (GO:0030208) | 3.55164801 |
| 78 | hemoglobin metabolic process (GO:0020027) | 3.53537653 |
| 79 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.52605169 |
| 80 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.51533753 |
| 81 | chondrocyte proliferation (GO:0035988) | 3.50338462 |
| 82 | folic acid transport (GO:0015884) | 3.49482593 |
| 83 | positive regulation of blood coagulation (GO:0030194) | 3.49079903 |
| 84 | positive regulation of hemostasis (GO:1900048) | 3.49079903 |
| 85 | * platelet degranulation (GO:0002576) | 3.46327071 |
| 86 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.45013117 |
| 87 | craniofacial suture morphogenesis (GO:0097094) | 3.44853916 |
| 88 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.42216168 |
| 89 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.41649305 |
| 90 | stress fiber assembly (GO:0043149) | 3.38740691 |
| 91 | beta-amyloid metabolic process (GO:0050435) | 3.37895439 |
| 92 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.35430179 |
| 93 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.35386048 |
| 94 | collagen fibril organization (GO:0030199) | 3.35163517 |
| 95 | adhesion of symbiont to host cell (GO:0044650) | 3.34855473 |
| 96 | virion attachment to host cell (GO:0019062) | 3.34855473 |
| 97 | regulation of mast cell activation (GO:0033003) | 3.34187243 |
| 98 | cellular response to interferon-alpha (GO:0035457) | 3.33695899 |
| 99 | positive regulation of mast cell degranulation (GO:0043306) | 3.31282980 |
| 100 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.31282980 |
| 101 | positive regulation of vesicle fusion (GO:0031340) | 3.29387786 |
| 102 | purinergic receptor signaling pathway (GO:0035587) | 3.29271224 |
| 103 | negative regulation of heart contraction (GO:0045822) | 3.26341991 |
| 104 | negative regulation of fibrinolysis (GO:0051918) | 3.26100619 |
| 105 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.23282601 |
| 106 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.22343821 |
| 107 | positive regulation of coagulation (GO:0050820) | 3.21278378 |
| 108 | leukocyte degranulation (GO:0043299) | 3.21249337 |
| 109 | dermatan sulfate metabolic process (GO:0030205) | 3.16050607 |
| 110 | positive regulation of macrophage activation (GO:0043032) | 3.15666053 |
| 111 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.12876328 |
| 112 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.11711054 |
| 113 | high-density lipoprotein particle remodeling (GO:0034375) | 3.11489120 |
| 114 | regulation of cholesterol efflux (GO:0010874) | 3.11071649 |
| 115 | negative regulation of T cell apoptotic process (GO:0070233) | 3.11020002 |
| 116 | phagocytosis, engulfment (GO:0006911) | 3.10928756 |
| 117 | barbed-end actin filament capping (GO:0051016) | 3.10697770 |
| 118 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.06868158 |
| 119 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.06868158 |
| 120 | regulation of mast cell degranulation (GO:0043304) | 3.06197034 |
| 121 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.05782914 |
| 122 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 3.04613794 |
| 123 | autophagic vacuole fusion (GO:0000046) | 3.04046717 |
| 124 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.02837286 |
| 125 | protein maturation by protein folding (GO:0022417) | 3.02803484 |
| 126 | regulation of hemostasis (GO:1900046) | 3.02600733 |
| 127 | regulation of blood coagulation (GO:0030193) | 3.02600733 |
| 128 | reverse cholesterol transport (GO:0043691) | 3.02358594 |
| 129 | aldehyde catabolic process (GO:0046185) | 3.00072685 |
| 130 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.99937056 |
| 131 | phospholipid homeostasis (GO:0055091) | 2.99375843 |
| 132 | extracellular matrix assembly (GO:0085029) | 2.99062490 |
| 133 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.98234763 |
| 134 | peptide catabolic process (GO:0043171) | 2.98077346 |
| 135 | L-ascorbic acid metabolic process (GO:0019852) | 2.96482035 |
| 136 | termination of signal transduction (GO:0023021) | 2.96114918 |
| 137 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.95328433 |
| 138 | regulation of receptor recycling (GO:0001919) | 2.95253782 |
| 139 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.94373078 |
| 140 | cyclooxygenase pathway (GO:0019371) | 2.92385259 |
| 141 | cortical actin cytoskeleton organization (GO:0030866) | 2.92270690 |
| 142 | endodermal cell differentiation (GO:0035987) | 2.91596116 |
| 143 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.91184298 |
| 144 | mitochondrial calcium ion transport (GO:0006851) | 2.88600241 |
| 145 | COPII vesicle coating (GO:0048208) | 2.88194161 |
| 146 | homotypic cell-cell adhesion (GO:0034109) | 2.87131472 |
| 147 | purine nucleotide salvage (GO:0032261) | 2.85812701 |
| 148 | epoxygenase P450 pathway (GO:0019373) | 2.85125046 |
| 149 | regulation of regulatory T cell differentiation (GO:0045589) | 2.85063147 |
| 150 | regulation of endothelial cell differentiation (GO:0045601) | 2.84922052 |
| 151 | regulation of norepinephrine secretion (GO:0014061) | 2.84736708 |
| 152 | superoxide anion generation (GO:0042554) | 2.84101673 |
| 153 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.82025359 |
| 154 | positive regulation of B cell mediated immunity (GO:0002714) | 2.82025359 |
| 155 | negative regulation of interleukin-17 production (GO:0032700) | 2.81763872 |
| 156 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.81038450 |
| 157 | adhesion of symbiont to host (GO:0044406) | 2.80476374 |
| 158 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.80272006 |
| 159 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.79863539 |
| 160 | membrane invagination (GO:0010324) | 2.79706979 |
| 161 | neutrophil activation involved in immune response (GO:0002283) | 2.79417514 |
| 162 | myeloid cell activation involved in immune response (GO:0002275) | 2.78063685 |
| 163 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.77260528 |
| 164 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.75906095 |
| 165 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.75745941 |
| 166 | negative regulation of membrane potential (GO:0045837) | 2.75495635 |
| 167 | regulation of coagulation (GO:0050818) | 2.75231802 |
| 168 | sequestering of actin monomers (GO:0042989) | 2.73024367 |
| 169 | cellular response to vitamin (GO:0071295) | 2.72848031 |
| 170 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.72779719 |
| 171 | response to arsenic-containing substance (GO:0046685) | 2.72471520 |
| 172 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.72394869 |
| 173 | regulation of monocyte chemotaxis (GO:0090025) | 2.71918810 |
| 174 | positive regulation of collagen biosynthetic process (GO:0032967) | 2.71916359 |
| 175 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.71548004 |
| 176 | wound healing (GO:0042060) | 2.71462033 |
| 177 | regulation of protein kinase C signaling (GO:0090036) | 2.70813069 |
| 178 | regulation of plasminogen activation (GO:0010755) | 2.70549564 |
| 179 | negative regulation of cytokine secretion (GO:0050710) | 2.66881408 |
| 180 | gland morphogenesis (GO:0022612) | 2.65493542 |
| 181 | cellular response to nutrient (GO:0031670) | 2.62783061 |
| 182 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.62361721 |
| 183 | positive regulation of chemokine secretion (GO:0090197) | 2.58166700 |
| 184 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.57968526 |
| 185 | cortical cytoskeleton organization (GO:0030865) | 2.57441857 |
| 186 | response to fluid shear stress (GO:0034405) | 2.55383663 |
| 187 | extracellular negative regulation of signal transduction (GO:1900116) | 2.54849715 |
| 188 | extracellular regulation of signal transduction (GO:1900115) | 2.54849715 |
| 189 | positive regulation of collagen metabolic process (GO:0010714) | 2.54456631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 7.48413178 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.25242728 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 5.69515693 |
| 4 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.71834305 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.42106784 |
| 6 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.21976432 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.01205896 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.18668961 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.16346978 |
| 10 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.99921427 |
| 11 | GATA1_19941826_ChIP-Seq_K562_Human | 2.93023460 |
| 12 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.85368371 |
| 13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.76828625 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.71809687 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.68816158 |
| 16 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.68755569 |
| 17 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.60314037 |
| 18 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.58919194 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.55289576 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.54362546 |
| 21 | GATA2_19941826_ChIP-Seq_K562_Human | 2.52169598 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.48168813 |
| 23 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.47980564 |
| 24 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.40345527 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23772226 |
| 26 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.21307901 |
| 27 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.15666857 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15307357 |
| 29 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.10921961 |
| 30 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.08869906 |
| 31 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.04827186 |
| 32 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.01035909 |
| 33 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.01035909 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.00301823 |
| 35 | CJUN_26792858_Chip-Seq_BT549_Human | 2.00168785 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.98034483 |
| 37 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.97985355 |
| 38 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.96833579 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.96710181 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95310344 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.91500462 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90649399 |
| 43 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.89580978 |
| 44 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.89580978 |
| 45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.85925631 |
| 46 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.83437006 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.79564387 |
| 48 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.77000213 |
| 49 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.76808431 |
| 50 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75955373 |
| 51 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.74812706 |
| 52 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.73655061 |
| 53 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.73304209 |
| 54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72017032 |
| 55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.71015203 |
| 56 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.68857602 |
| 57 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.68698595 |
| 58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68516524 |
| 59 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.68446454 |
| 60 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.66897919 |
| 61 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.66719447 |
| 62 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.64444958 |
| 63 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.61977927 |
| 64 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.61047590 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57538542 |
| 66 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56846125 |
| 67 | ATF3_27146783_Chip-Seq_COLON_Human | 1.54753882 |
| 68 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.52218734 |
| 69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51849164 |
| 70 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50107785 |
| 71 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.49667429 |
| 72 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.46741677 |
| 73 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.46630295 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46586388 |
| 75 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.46107582 |
| 76 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.43739803 |
| 77 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.43266707 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36211897 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34949726 |
| 80 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31703417 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31438677 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30086536 |
| 83 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.28588055 |
| 84 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27011905 |
| 85 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.24617860 |
| 86 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22168330 |
| 87 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.22018362 |
| 88 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.20670082 |
| 89 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.20666805 |
| 90 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20244165 |
| 91 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19240727 |
| 92 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18681675 |
| 93 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.18427586 |
| 94 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17781729 |
| 95 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16363425 |
| 96 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15977292 |
| 97 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.15756276 |
| 98 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.15683293 |
| 99 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.13918526 |
| 100 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.12867563 |
| 101 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12402624 |
| 102 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.12372842 |
| 103 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.11830333 |
| 104 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.10979577 |
| 105 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09847716 |
| 106 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09554368 |
| 107 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09421851 |
| 108 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.09193974 |
| 109 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08666884 |
| 110 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08502568 |
| 111 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06595971 |
| 112 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.06520055 |
| 113 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05196443 |
| 114 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04019955 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03500311 |
| 116 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.03462299 |
| 117 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.03223912 |
| 118 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.02395583 |
| 119 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.02081341 |
| 120 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01857078 |
| 121 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01611599 |
| 122 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01264993 |
| 123 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00034598 |
| 124 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99768244 |
| 125 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99559226 |
| 126 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99173296 |
| 127 | MYB_26560356_Chip-Seq_TH2_Human | 0.99025979 |
| 128 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98034711 |
| 129 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97899385 |
| 130 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97868235 |
| 131 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97247877 |
| 132 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97018788 |
| 133 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95618929 |
| 134 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.95199460 |
| 135 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94871963 |
| 136 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94249900 |
| 137 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93714891 |
| 138 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.93467291 |
| 139 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.91724769 |
| 140 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91069190 |
| 141 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.89737418 |
| 142 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89248770 |
| 143 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88691386 |
| 144 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87255155 |
| 145 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86791598 |
| 146 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.85371719 |
| 147 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82946619 |
| 148 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.82889450 |
| 149 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.82833370 |
| 150 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82631139 |
| 151 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.82287833 |
| 152 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82066587 |
| 153 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.81961755 |
| 154 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.81734782 |
| 155 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.80877275 |
| 156 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.80566016 |
| 157 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.80451392 |
| 158 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.80228123 |
| 159 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80087476 |
| 160 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.79874696 |
| 161 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.79723823 |
| 162 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79439734 |
| 163 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.79367071 |
| 164 | GATA1_22025678_ChIP-Seq_K562_Human | 0.78216418 |
| 165 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.77531802 |
| 166 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.76614633 |
| 167 | VDR_22108803_ChIP-Seq_LS180_Human | 0.75994873 |
| 168 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75973897 |
| 169 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75719602 |
| 170 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75711607 |
| 171 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.75623027 |
| 172 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.75587586 |
| 173 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.75559574 |
| 174 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.75063360 |
| 175 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74812773 |
| 176 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.74701630 |
| 177 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74547337 |
| 178 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74392763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 7.11730392 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 5.59633269 |
| 3 | MP0003279_aneurysm | 5.24896125 |
| 4 | MP0005275_abnormal_skin_tensile | 4.48470870 |
| 5 | MP0009384_cardiac_valve_regurgitation | 4.28537305 |
| 6 | MP0001958_emphysema | 4.14747919 |
| 7 | MP0000465_gastrointestinal_hemorrhage | 3.29754887 |
| 8 | MP0004510_myositis | 3.14068624 |
| 9 | MP0005503_abnormal_tendon_morphology | 3.03818267 |
| 10 | MP0002295_abnormal_pulmonary_circulatio | 2.92652453 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.92567963 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.85017020 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.79806550 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.54502182 |
| 15 | MP0005023_abnormal_wound_healing | 2.51319611 |
| 16 | MP0010368_abnormal_lymphatic_system | 2.42416751 |
| 17 | MP0005167_abnormal_blood-brain_barrier | 2.22894398 |
| 18 | MP0006054_spinal_hemorrhage | 1.94273579 |
| 19 | MP0005671_abnormal_response_to | 1.89070775 |
| 20 | MP0000230_abnormal_systemic_arterial | 1.87846163 |
| 21 | MP0001533_abnormal_skeleton_physiology | 1.83981536 |
| 22 | MP0003091_abnormal_cell_migration | 1.83594545 |
| 23 | MP0004272_abnormal_basement_membrane | 1.76922942 |
| 24 | MP0005595_abnormal_vascular_smooth | 1.72410021 |
| 25 | MP0003638_abnormal_response/metabolism_ | 1.68646048 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.67900194 |
| 27 | MP0002736_abnormal_nociception_after | 1.67137888 |
| 28 | MP0005084_abnormal_gallbladder_morpholo | 1.64109228 |
| 29 | MP0004130_abnormal_muscle_cell | 1.62031189 |
| 30 | MP0001879_abnormal_lymphatic_vessel | 1.57546311 |
| 31 | MP0003186_abnormal_redox_activity | 1.56598728 |
| 32 | MP0005164_abnormal_response_to | 1.55323254 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.51800531 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.51800531 |
| 35 | MP0000013_abnormal_adipose_tissue | 1.51777254 |
| 36 | MP0000343_altered_response_to | 1.51713636 |
| 37 | MP0001243_abnormal_dermal_layer | 1.51607633 |
| 38 | MP0001542_abnormal_bone_strength | 1.51244362 |
| 39 | MP0004036_abnormal_muscle_relaxation | 1.49665459 |
| 40 | MP0005410_abnormal_fertilization | 1.48675185 |
| 41 | MP0003436_decreased_susceptibility_to | 1.44105066 |
| 42 | MP0002060_abnormal_skin_morphology | 1.44089453 |
| 43 | MP0002398_abnormal_bone_marrow | 1.42556349 |
| 44 | MP0002723_abnormal_immune_serum | 1.40838130 |
| 45 | MP0005083_abnormal_biliary_tract | 1.38125997 |
| 46 | MP0000750_abnormal_muscle_regeneration | 1.37818469 |
| 47 | MP0001800_abnormal_humoral_immune | 1.35094920 |
| 48 | MP0000858_altered_metastatic_potential | 1.32692498 |
| 49 | MP0001663_abnormal_digestive_system | 1.32003887 |
| 50 | MP0008872_abnormal_physiological_respon | 1.30718728 |
| 51 | MP0008004_abnormal_stomach_pH | 1.29010293 |
| 52 | MP0005390_skeleton_phenotype | 1.27310008 |
| 53 | MP0005623_abnormal_meninges_morphology | 1.27073343 |
| 54 | MP0003303_peritoneal_inflammation | 1.25786424 |
| 55 | MP0003879_abnormal_hair_cell | 1.23469591 |
| 56 | MP0000767_abnormal_smooth_muscle | 1.23002746 |
| 57 | MP0002132_abnormal_respiratory_system | 1.22773026 |
| 58 | MP0005025_abnormal_response_to | 1.19718568 |
| 59 | MP0003950_abnormal_plasma_membrane | 1.19306907 |
| 60 | MP0002420_abnormal_adaptive_immunity | 1.18466291 |
| 61 | MP0001177_atelectasis | 1.17968512 |
| 62 | MP0001819_abnormal_immune_cell | 1.17023270 |
| 63 | MP0005387_immune_system_phenotype | 1.16022951 |
| 64 | MP0001790_abnormal_immune_system | 1.16022951 |
| 65 | MP0010329_abnormal_lipoprotein_level | 1.15142217 |
| 66 | MP0005646_abnormal_pituitary_gland | 1.14180360 |
| 67 | MP0008874_decreased_physiological_sensi | 1.08787890 |
| 68 | MP0001299_abnormal_eye_distance/ | 1.08256246 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.06876566 |
| 70 | MP0002133_abnormal_respiratory_system | 1.06611331 |
| 71 | MP0005388_respiratory_system_phenotype | 1.06611331 |
| 72 | MP0002429_abnormal_blood_cell | 1.06585873 |
| 73 | MP0000249_abnormal_blood_vessel | 1.05613362 |
| 74 | MP0008775_abnormal_heart_ventricle | 1.05143987 |
| 75 | MP0005508_abnormal_skeleton_morphology | 1.04001900 |
| 76 | MP0003866_abnormal_defecation | 1.01491030 |
| 77 | MP0003724_increased_susceptibility_to | 1.00093081 |
| 78 | MP0002419_abnormal_innate_immunity | 0.99429206 |
| 79 | MP0002733_abnormal_thermal_nociception | 0.99352207 |
| 80 | MP0001348_abnormal_lacrimal_gland | 0.99168528 |
| 81 | MP0001968_abnormal_touch/_nociception | 0.97334541 |
| 82 | MP0000716_abnormal_immune_system | 0.96326648 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.96238184 |
| 84 | MP0002405_respiratory_system_inflammati | 0.93959787 |
| 85 | MP0009764_decreased_sensitivity_to | 0.93481802 |
| 86 | MP0004215_abnormal_myocardial_fiber | 0.92366350 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 0.92340382 |
| 88 | MP0010030_abnormal_orbit_morphology | 0.92285459 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.91018109 |
| 90 | MP0004233_abnormal_muscle_weight | 0.90695752 |
| 91 | MP0005360_urolithiasis | 0.90638085 |
| 92 | MP0002722_abnormal_immune_system | 0.90586230 |
| 93 | MP0004084_abnormal_cardiac_muscle | 0.90111442 |
| 94 | MP0002128_abnormal_blood_circulation | 0.89143449 |
| 95 | MP0009642_abnormal_blood_homeostasis | 0.86925990 |
| 96 | MP0009278_abnormal_bone_marrow | 0.85755650 |
| 97 | MP0002089_abnormal_postnatal_growth/wei | 0.83743653 |
| 98 | MP0005058_abnormal_lysosome_morphology | 0.83474989 |
| 99 | MP0003448_altered_tumor_morphology | 0.82261948 |
| 100 | MP0002148_abnormal_hypersensitivity_rea | 0.80838998 |
| 101 | MP0009785_altered_susceptibility_to | 0.80796898 |
| 102 | MP0005000_abnormal_immune_tolerance | 0.80727235 |
| 103 | MP0005381_digestive/alimentary_phenotyp | 0.79965143 |
| 104 | MP0001765_abnormal_ion_homeostasis | 0.77020056 |
| 105 | MP0004484_altered_response_of | 0.76543375 |
| 106 | MP0003075_altered_response_to | 0.76151283 |
| 107 | MP0003795_abnormal_bone_structure | 0.75429397 |
| 108 | MP0000163_abnormal_cartilage_morphology | 0.73623781 |
| 109 | MP0005165_increased_susceptibility_to | 0.72905000 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.72478738 |
| 111 | MP0003329_amyloid_beta_deposits | 0.72336409 |
| 112 | MP0002998_abnormal_bone_remodeling | 0.70518727 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.70453378 |
| 114 | MP0003300_gastrointestinal_ulcer | 0.70449569 |
| 115 | MP0001544_abnormal_cardiovascular_syste | 0.69590484 |
| 116 | MP0005385_cardiovascular_system_phenoty | 0.69590484 |
| 117 | MP0003045_fibrosis | 0.69523109 |
| 118 | MP0001853_heart_inflammation | 0.69422080 |
| 119 | MP0001614_abnormal_blood_vessel | 0.69376596 |
| 120 | MP0000759_abnormal_skeletal_muscle | 0.69211843 |
| 121 | MP0001970_abnormal_pain_threshold | 0.68905953 |
| 122 | MP0005409_darkened_coat_color | 0.68864554 |
| 123 | MP0005174_abnormal_tail_pigmentation | 0.65745995 |
| 124 | MP0001664_abnormal_digestion | 0.65668850 |
| 125 | MP0000604_amyloidosis | 0.65505490 |
| 126 | MP0004883_abnormal_blood_vessel | 0.65438641 |
| 127 | MP0005365_abnormal_bile_salt | 0.65006596 |
| 128 | MP0001756_abnormal_urination | 0.64816675 |
| 129 | MP0001849_ear_inflammation | 0.63837556 |
| 130 | MP0008260_abnormal_autophagy | 0.63630653 |
| 131 | MP0005670_abnormal_white_adipose | 0.63303512 |
| 132 | MP0003172_abnormal_lysosome_physiology | 0.63295690 |
| 133 | MP0006138_congestive_heart_failure | 0.62908921 |
| 134 | MP0002933_joint_inflammation | 0.62561446 |
| 135 | MP0002118_abnormal_lipid_homeostasis | 0.62469901 |
| 136 | MP0005620_abnormal_muscle_contractility | 0.62081261 |
| 137 | MP0009697_abnormal_copulation | 0.61086948 |
| 138 | MP0001915_intracranial_hemorrhage | 0.59821989 |
| 139 | MP0002896_abnormal_bone_mineralization | 0.58748996 |
| 140 | MP0003115_abnormal_respiratory_system | 0.58650954 |
| 141 | MP0003453_abnormal_keratinocyte_physiol | 0.58477371 |
| 142 | MP0004947_skin_inflammation | 0.57504621 |
| 143 | MP0009333_abnormal_splenocyte_physiolog | 0.57159091 |
| 144 | MP0003828_pulmonary_edema | 0.56728626 |
| 145 | MP0003385_abnormal_body_wall | 0.56657840 |
| 146 | MP0000685_abnormal_immune_system | 0.56499442 |
| 147 | MP0001845_abnormal_inflammatory_respons | 0.55702563 |
| 148 | MP0001175_abnormal_lung_morphology | 0.55518567 |
| 149 | MP0002452_abnormal_antigen_presenting | 0.55249325 |
| 150 | MP0001851_eye_inflammation | 0.54779475 |
| 151 | MP0000627_abnormal_mammary_gland | 0.54547542 |
| 152 | MP0002972_abnormal_cardiac_muscle | 0.52666858 |
| 153 | MP0000733_abnormal_muscle_development | 0.52429794 |
| 154 | MP0002168_other_aberrant_phenotype | 0.52339859 |
| 155 | MP0002396_abnormal_hematopoietic_system | 0.51660120 |
| 156 | MP0010234_abnormal_vibrissa_follicle | 0.51598678 |
| 157 | MP0002115_abnormal_skeleton_extremities | 0.51272824 |
| 158 | MP0009763_increased_sensitivity_to | 0.51148865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 9.93701583 |
| 2 | Abnormal platelet volume (HP:0011876) | 9.88601615 |
| 3 | Aortic aneurysm (HP:0004942) | 8.94935371 |
| 4 | Epistaxis (HP:0000421) | 7.73641348 |
| 5 | Cerebral aneurysm (HP:0004944) | 7.18806143 |
| 6 | Protrusio acetabuli (HP:0003179) | 7.09236105 |
| 7 | Gingival bleeding (HP:0000225) | 6.85676931 |
| 8 | Aortic dissection (HP:0002647) | 6.39216253 |
| 9 | Premature rupture of membranes (HP:0001788) | 6.09840817 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.99274669 |
| 11 | Impaired platelet aggregation (HP:0003540) | 5.74222842 |
| 12 | Abnormal platelet function (HP:0011869) | 5.74222842 |
| 13 | Dilatation of the ascending aorta (HP:0005111) | 5.60802411 |
| 14 | Peritonitis (HP:0002586) | 5.39123274 |
| 15 | Vertebral compression fractures (HP:0002953) | 4.95712395 |
| 16 | Spontaneous hematomas (HP:0007420) | 4.71315824 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 4.70913505 |
| 18 | Vascular tortuosity (HP:0004948) | 4.66392440 |
| 19 | Gastrointestinal dysmotility (HP:0002579) | 4.57297508 |
| 20 | Abnormal pupillary function (HP:0007686) | 4.56364658 |
| 21 | Arterial tortuosity (HP:0005116) | 4.51984045 |
| 22 | Soft skin (HP:0000977) | 4.32786933 |
| 23 | Poikilocytosis (HP:0004447) | 4.04210991 |
| 24 | Conjunctival telangiectasia (HP:0000524) | 4.03720952 |
| 25 | Atrophic scars (HP:0001075) | 3.85178053 |
| 26 | Acanthocytosis (HP:0001927) | 3.78823882 |
| 27 | Wormian bones (HP:0002645) | 3.63877949 |
| 28 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.63831811 |
| 29 | Aneurysm (HP:0002617) | 3.53862716 |
| 30 | Joint stiffness (HP:0001387) | 3.50076413 |
| 31 | Bruising susceptibility (HP:0000978) | 3.45820319 |
| 32 | Distal arthrogryposis (HP:0005684) | 3.35794934 |
| 33 | Wrist flexion contracture (HP:0001239) | 3.33845952 |
| 34 | Round ear (HP:0100830) | 3.31715575 |
| 35 | Blue sclerae (HP:0000592) | 3.31700448 |
| 36 | Paralysis (HP:0003470) | 3.29723556 |
| 37 | Dyschromatopsia (HP:0007641) | 3.28745539 |
| 38 | Bladder diverticulum (HP:0000015) | 3.17585170 |
| 39 | Overgrowth (HP:0001548) | 3.13121399 |
| 40 | Coxa vara (HP:0002812) | 3.09663602 |
| 41 | Abnormality of macrophages (HP:0004311) | 3.09163934 |
| 42 | Biconcave vertebral bodies (HP:0004586) | 3.07402825 |
| 43 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.06959425 |
| 44 | Hand muscle atrophy (HP:0009130) | 3.01436402 |
| 45 | Fragile skin (HP:0001030) | 2.88827889 |
| 46 | Shallow orbits (HP:0000586) | 2.86944575 |
| 47 | Hepatosplenomegaly (HP:0001433) | 2.86801411 |
| 48 | Nemaline bodies (HP:0003798) | 2.86408907 |
| 49 | Abnormality of lateral ventricle (HP:0030047) | 2.86285668 |
| 50 | Type 1 muscle fiber predominance (HP:0003803) | 2.84370265 |
| 51 | Stomatitis (HP:0010280) | 2.83827501 |
| 52 | Distal lower limb muscle weakness (HP:0009053) | 2.75695328 |
| 53 | Xanthomatosis (HP:0000991) | 2.69500377 |
| 54 | Abnormality of dentin (HP:0010299) | 2.68951938 |
| 55 | Upper limb amyotrophy (HP:0009129) | 2.68870319 |
| 56 | Distal upper limb amyotrophy (HP:0007149) | 2.68870319 |
| 57 | Scapular winging (HP:0003691) | 2.60506041 |
| 58 | Joint swelling (HP:0001386) | 2.57004201 |
| 59 | Spinal rigidity (HP:0003306) | 2.51540541 |
| 60 | Joint hemorrhage (HP:0005261) | 2.49399000 |
| 61 | Eczematoid dermatitis (HP:0000976) | 2.44231757 |
| 62 | Abnormality of iron homeostasis (HP:0011031) | 2.43906528 |
| 63 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.40525427 |
| 64 | Increased connective tissue (HP:0009025) | 2.36450727 |
| 65 | Beaking of vertebral bodies (HP:0004568) | 2.35939442 |
| 66 | Tinnitus (HP:0000360) | 2.34178663 |
| 67 | Bowel diverticulosis (HP:0005222) | 2.32815944 |
| 68 | Ulnar deviation of the wrist (HP:0003049) | 2.32382509 |
| 69 | Calcaneovalgus deformity (HP:0001848) | 2.31090930 |
| 70 | Abnormal auditory evoked potentials (HP:0006958) | 2.28627225 |
| 71 | Increased IgM level (HP:0003496) | 2.27894505 |
| 72 | Bradycardia (HP:0001662) | 2.26565448 |
| 73 | Hyperextensible skin (HP:0000974) | 2.23294716 |
| 74 | Facial diplegia (HP:0001349) | 2.22755395 |
| 75 | Trismus (HP:0000211) | 2.19416177 |
| 76 | Elbow flexion contracture (HP:0002987) | 2.19332336 |
| 77 | Nausea (HP:0002018) | 2.18514550 |
| 78 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17993669 |
| 79 | Obstructive lung disease (HP:0006536) | 2.17993669 |
| 80 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.17471914 |
| 81 | Abnormality of the acetabulum (HP:0003170) | 2.17082217 |
| 82 | Upper limb muscle weakness (HP:0003484) | 2.16983806 |
| 83 | Generalized aminoaciduria (HP:0002909) | 2.16741816 |
| 84 | Myopathic facies (HP:0002058) | 2.15738568 |
| 85 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.13721270 |
| 86 | Increased serum ferritin (HP:0003281) | 2.12915535 |
| 87 | Papillary thyroid carcinoma (HP:0002895) | 2.12701522 |
| 88 | Abnormality of the calcaneus (HP:0008364) | 2.12635924 |
| 89 | Abnormality of the peritoneum (HP:0002585) | 2.12204136 |
| 90 | Muscle fiber inclusion bodies (HP:0100299) | 2.11728880 |
| 91 | Mitral stenosis (HP:0001718) | 2.11163047 |
| 92 | Myocardial infarction (HP:0001658) | 2.09183690 |
| 93 | Arterial thrombosis (HP:0004420) | 2.08896272 |
| 94 | Cervical subluxation (HP:0003308) | 2.06780710 |
| 95 | Male infertility (HP:0003251) | 2.06718525 |
| 96 | Abnormal delivery (HP:0001787) | 2.05603368 |
| 97 | Deformed tarsal bones (HP:0008119) | 2.03031143 |
| 98 | Increased density of long bones (HP:0006392) | 2.02444429 |
| 99 | Ectopia lentis (HP:0001083) | 2.02006022 |
| 100 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.01169603 |
| 101 | Prolonged bleeding time (HP:0003010) | 11.5188563 |
| 102 | Menorrhagia (HP:0000132) | 10.5117617 |
| 103 | Increased mean platelet volume (HP:0011877) | 10.4854312 |
| 104 | Ileus (HP:0002595) | 1.98431454 |
| 105 | Spontaneous abortion (HP:0005268) | 1.98220635 |
| 106 | Recurrent abscess formation (HP:0002722) | 1.97396413 |
| 107 | Abnormal hemoglobin (HP:0011902) | 1.97289101 |
| 108 | Short nail (HP:0001799) | 1.97251231 |
| 109 | Cardiovascular calcification (HP:0011915) | 1.96354249 |
| 110 | Dysostosis multiplex (HP:0000943) | 1.95389838 |
| 111 | Recurrent bacterial skin infections (HP:0005406) | 1.93182897 |
| 112 | Decreased central vision (HP:0007663) | 1.91832829 |
| 113 | Tachypnea (HP:0002789) | 1.91635427 |
| 114 | Infantile muscular hypotonia (HP:0008947) | 1.88775757 |
| 115 | Encephalitis (HP:0002383) | 1.88667788 |
| 116 | Episodic fever (HP:0001954) | 1.88441652 |
| 117 | Spondylolisthesis (HP:0003302) | 1.88394811 |
| 118 | Ventricular fibrillation (HP:0001663) | 1.87708237 |
| 119 | Broad metatarsal (HP:0001783) | 1.85403057 |
| 120 | Dysautonomia (HP:0002459) | 1.84655321 |
| 121 | Genu recurvatum (HP:0002816) | 1.83057738 |
| 122 | Basal ganglia calcification (HP:0002135) | 1.82271829 |
| 123 | Heterochromia iridis (HP:0001100) | 1.80914767 |
| 124 | Abnormality of the prostate (HP:0008775) | 1.80439190 |
| 125 | Abnormality of the pericardium (HP:0001697) | 1.79346806 |
| 126 | Coxa valga (HP:0002673) | 1.79280537 |
| 127 | Polycythemia (HP:0001901) | 1.79170907 |
| 128 | Absent phalangeal crease (HP:0006109) | 1.75123873 |
| 129 | Thyroid-stimulating hormone excess (HP:0002925) | 1.74649755 |
| 130 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.73943127 |
| 131 | Autoimmune hemolytic anemia (HP:0001890) | 1.73342079 |
| 132 | Decreased muscle mass (HP:0003199) | 1.72808577 |
| 133 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.71959866 |
| 134 | 3-Methylglutaconic aciduria (HP:0003535) | 1.71732414 |
| 135 | Vertigo (HP:0002321) | 1.71206677 |
| 136 | Hypophosphatemic rickets (HP:0004912) | 1.68030473 |
| 137 | Osteopenia (HP:0000938) | 1.66388566 |
| 138 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.65505858 |
| 139 | Abnormality of the intrinsic pathway (HP:0010989) | 1.64563111 |
| 140 | Congenital glaucoma (HP:0001087) | 1.64147771 |
| 141 | Ankle contracture (HP:0006466) | 1.63395304 |
| 142 | Difficulty climbing stairs (HP:0003551) | 1.63385182 |
| 143 | Long palpebral fissure (HP:0000637) | 1.62767614 |
| 144 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.62239195 |
| 145 | Osteolytic defects of the hand bones (HP:0009699) | 1.62239195 |
| 146 | Chest pain (HP:0100749) | 1.61809483 |
| 147 | Distal lower limb amyotrophy (HP:0008944) | 1.61161784 |
| 148 | Tongue fasciculations (HP:0001308) | 1.61147387 |
| 149 | Abnormality of the common coagulation pathway (HP:0010990) | 1.59646884 |
| 150 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.59461400 |
| 151 | Mucosal telangiectasiae (HP:0100579) | 1.59098765 |
| 152 | Bifid uvula (HP:0000193) | 1.58687657 |
| 153 | Broad face (HP:0000283) | 1.58300777 |
| 154 | Thin skin (HP:0000963) | 1.58241781 |
| 155 | Leiomyosarcoma (HP:0100243) | 1.57040236 |
| 156 | Uterine leiomyosarcoma (HP:0002891) | 1.57040236 |
| 157 | Hyperthyroidism (HP:0000836) | 1.57029637 |
| 158 | Biliary tract neoplasm (HP:0100574) | 1.56569346 |
| 159 | Mitral valve prolapse (HP:0001634) | 1.56303872 |
| 160 | Mitral regurgitation (HP:0001653) | 1.56202930 |
| 161 | Emphysema (HP:0002097) | 1.55938498 |
| 162 | Muscle fibrillation (HP:0010546) | 1.54271413 |
| 163 | Camptodactyly of toe (HP:0001836) | 1.52577656 |
| 164 | Nonimmune hydrops fetalis (HP:0001790) | 1.52409818 |
| 165 | Knee flexion contracture (HP:0006380) | 1.52240889 |
| 166 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.51333040 |
| 167 | Abnormal ciliary motility (HP:0012262) | 1.51293524 |
| 168 | Back pain (HP:0003418) | 1.50362557 |
| 169 | Opisthotonus (HP:0002179) | 1.50177877 |
| 170 | Thrombophlebitis (HP:0004418) | 1.49992100 |
| 171 | Aortic valve stenosis (HP:0001650) | 1.49706093 |
| 172 | Arthropathy (HP:0003040) | 1.49460092 |
| 173 | Polyphagia (HP:0002591) | 1.49155375 |
| 174 | Purpura (HP:0000979) | 1.48805988 |
| 175 | Autoamputation (HP:0001218) | 1.48608741 |
| 176 | Abnormality of binocular vision (HP:0011514) | 1.47374307 |
| 177 | Diplopia (HP:0000651) | 1.47374307 |
| 178 | Thrombocytosis (HP:0001894) | 1.45972706 |
| 179 | Abnormal spermatogenesis (HP:0008669) | 1.45463352 |
| 180 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.44431881 |
| 181 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.42752296 |
| 182 | Increased cerebral lipofuscin (HP:0011813) | 1.41742980 |
| 183 | Visual hallucinations (HP:0002367) | 1.41717078 |
| 184 | Thyroid carcinoma (HP:0002890) | 1.38690385 |
| 185 | Amaurosis fugax (HP:0100576) | 1.38134074 |
| 186 | Leukocytosis (HP:0001974) | 1.36801404 |
| 187 | Bladder carcinoma (HP:0002862) | 1.36762698 |
| 188 | Bladder neoplasm (HP:0009725) | 1.36762698 |
| 189 | Cerebral hemorrhage (HP:0001342) | 1.35910193 |
| 190 | Cerebral ischemia (HP:0002637) | 1.34620268 |
| 191 | Infertility (HP:0000789) | 1.34289677 |
| 192 | Testicular neoplasm (HP:0010788) | 1.33929732 |
| 193 | Arthralgia (HP:0002829) | 1.33238806 |
| 194 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.32854419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK1 | 6.52561279 |
| 2 | LIMK1 | 5.19579079 |
| 3 | MST4 | 4.80671579 |
| 4 | PIK3CG | 4.51559320 |
| 5 | TESK2 | 3.61037770 |
| 6 | TEC | 3.08585282 |
| 7 | BTK | 3.01715283 |
| 8 | PIK3CA | 2.95742076 |
| 9 | PIM2 | 2.77921682 |
| 10 | MAPKAPK3 | 2.71015303 |
| 11 | SYK | 2.46728239 |
| 12 | TAOK3 | 2.43709444 |
| 13 | ERBB3 | 2.31504132 |
| 14 | MYLK | 2.31184909 |
| 15 | LATS2 | 2.30485703 |
| 16 | ERN1 | 2.28506673 |
| 17 | BMPR2 | 2.27483081 |
| 18 | CSF1R | 2.26792184 |
| 19 | ZAP70 | 2.15441746 |
| 20 | PTK2B | 2.10493254 |
| 21 | GRK5 | 2.08799838 |
| 22 | MINK1 | 2.01469152 |
| 23 | MAP3K11 | 1.98553353 |
| 24 | FGR | 1.97830266 |
| 25 | GRK6 | 1.91494526 |
| 26 | TTN | 1.91064094 |
| 27 | PAK3 | 1.83489873 |
| 28 | NME2 | 1.77894474 |
| 29 | TRPM7 | 1.77381060 |
| 30 | ARAF | 1.73102925 |
| 31 | BLK | 1.71067624 |
| 32 | EPHA2 | 1.70552046 |
| 33 | STK3 | 1.58117091 |
| 34 | HCK | 1.55180142 |
| 35 | RPS6KA4 | 1.50235876 |
| 36 | MAP3K3 | 1.43716291 |
| 37 | PAK2 | 1.43433726 |
| 38 | TRIB3 | 1.41439900 |
| 39 | DDR2 | 1.38643401 |
| 40 | MAP3K13 | 1.38154827 |
| 41 | KDR | 1.38129803 |
| 42 | FES | 1.36666290 |
| 43 | FER | 1.36557453 |
| 44 | ACVR1B | 1.32553602 |
| 45 | LYN | 1.29127490 |
| 46 | ADRBK2 | 1.26248173 |
| 47 | TAOK2 | 1.25625854 |
| 48 | MAP2K1 | 1.21943681 |
| 49 | TAOK1 | 1.20639536 |
| 50 | MATK | 1.16059901 |
| 51 | KSR2 | 1.11406623 |
| 52 | SCYL2 | 1.09663582 |
| 53 | CSK | 1.07257566 |
| 54 | TXK | 1.05332842 |
| 55 | MOS | 1.05167385 |
| 56 | LMTK2 | 1.04134424 |
| 57 | DAPK3 | 1.03949150 |
| 58 | SIK3 | 1.01014130 |
| 59 | EIF2AK1 | 1.00863400 |
| 60 | PBK | 1.00792389 |
| 61 | ITK | 0.99612042 |
| 62 | TNK2 | 0.99456895 |
| 63 | LRRK2 | 0.99356024 |
| 64 | MAP3K9 | 0.98755691 |
| 65 | MAP2K3 | 0.98038351 |
| 66 | PTK2 | 0.97628723 |
| 67 | STK24 | 0.96505426 |
| 68 | TNIK | 0.95130876 |
| 69 | CAMKK2 | 0.93376508 |
| 70 | ERBB2 | 0.92817946 |
| 71 | RAF1 | 0.89422112 |
| 72 | IRAK1 | 0.89035319 |
| 73 | MARK3 | 0.86831770 |
| 74 | PNCK | 0.83818185 |
| 75 | TLK1 | 0.81802919 |
| 76 | PAK1 | 0.81081281 |
| 77 | DAPK2 | 0.80816259 |
| 78 | PDK1 | 0.78206074 |
| 79 | CDC42BPA | 0.75720333 |
| 80 | TRIM28 | 0.74328777 |
| 81 | PKN2 | 0.74158127 |
| 82 | EPHB2 | 0.73373294 |
| 83 | MAP3K8 | 0.72897160 |
| 84 | ADRBK1 | 0.71968343 |
| 85 | STK10 | 0.70094856 |
| 86 | TBK1 | 0.68122783 |
| 87 | RET | 0.66730432 |
| 88 | RPS6KB2 | 0.64860194 |
| 89 | PDPK1 | 0.64828401 |
| 90 | MAP3K5 | 0.63155960 |
| 91 | RIPK4 | 0.62240591 |
| 92 | EPHA3 | 0.61326861 |
| 93 | STK4 | 0.60306728 |
| 94 | MAPK12 | 0.59723971 |
| 95 | EPHB1 | 0.59715720 |
| 96 | MAPKAPK5 | 0.58333330 |
| 97 | MET | 0.58052006 |
| 98 | LCK | 0.57624350 |
| 99 | ABL2 | 0.55561678 |
| 100 | BMX | 0.54614881 |
| 101 | PDGFRA | 0.53225829 |
| 102 | PDGFRB | 0.52412039 |
| 103 | FLT3 | 0.52022370 |
| 104 | PRKACG | 0.51240262 |
| 105 | FGFR1 | 0.51178826 |
| 106 | CDK14 | 0.50952996 |
| 107 | PRKD1 | 0.50732891 |
| 108 | JAK1 | 0.50549312 |
| 109 | JAK3 | 0.47927403 |
| 110 | TGFBR2 | 0.46855772 |
| 111 | ROCK1 | 0.46230349 |
| 112 | JAK2 | 0.45905577 |
| 113 | BMPR1B | 0.44551624 |
| 114 | PDK2 | 0.43852703 |
| 115 | BRAF | 0.42871812 |
| 116 | NEK9 | 0.42834334 |
| 117 | PKN1 | 0.42747061 |
| 118 | MAP3K1 | 0.41987563 |
| 119 | KSR1 | 0.40861888 |
| 120 | IRAK3 | 0.40727546 |
| 121 | NUAK1 | 0.40147933 |
| 122 | NTRK1 | 0.39217557 |
| 123 | ZAK | 0.39090286 |
| 124 | PAK4 | 0.39009552 |
| 125 | MAP3K12 | 0.38949356 |
| 126 | FYN | 0.38314739 |
| 127 | PRKG1 | 0.38256310 |
| 128 | PLK2 | 0.37459847 |
| 129 | IRAK4 | 0.37289512 |
| 130 | DAPK1 | 0.37167618 |
| 131 | CDK15 | 0.37038719 |
| 132 | MAP4K1 | 0.36857899 |
| 133 | MAPKAPK2 | 0.36313278 |
| 134 | BRSK2 | 0.33637070 |
| 135 | CDK18 | 0.33207566 |
| 136 | ILK | 0.32850962 |
| 137 | YES1 | 0.32627972 |
| 138 | EGFR | 0.32527775 |
| 139 | PRKCQ | 0.32527357 |
| 140 | CDK11A | 0.31628412 |
| 141 | PRKCD | 0.31437113 |
| 142 | CDK6 | 0.30758735 |
| 143 | PRKCB | 0.30411956 |
| 144 | PRKG2 | 0.30289827 |
| 145 | SRC | 0.30132967 |
| 146 | EIF2AK3 | 0.29409538 |
| 147 | SGK2 | 0.28350833 |
| 148 | INSR | 0.27507825 |
| 149 | PRKCA | 0.27467227 |
| 150 | PDK3 | 0.27064684 |
| 151 | PDK4 | 0.27064684 |
| 152 | MAPK13 | 0.25316634 |
| 153 | PAK6 | 0.25267100 |
| 154 | IKBKB | 0.24821569 |
| 155 | DYRK1B | 0.24078450 |
| 156 | ABL1 | 0.22506666 |
| 157 | PIM1 | 0.21893829 |
| 158 | IRAK2 | 0.21617049 |
| 159 | CAMKK1 | 0.20885030 |
| 160 | IGF1R | 0.20591959 |
| 161 | CAMK1G | 0.20197466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 4.24480289 |
| 2 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.13894765 |
| 3 | Shigellosis_Homo sapiens_hsa05131 | 3.11869715 |
| 4 | Malaria_Homo sapiens_hsa05144 | 2.95518963 |
| 5 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.76384340 |
| 6 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.63340883 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.51473511 |
| 8 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.21401229 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.19315725 |
| 10 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.11120343 |
| 11 | Phagosome_Homo sapiens_hsa04145 | 2.02744490 |
| 12 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.89296517 |
| 13 | Bladder cancer_Homo sapiens_hsa05219 | 1.83952859 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.80804127 |
| 15 | Salmonella infection_Homo sapiens_hsa05132 | 1.76153069 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.75952206 |
| 17 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.75741455 |
| 18 | Focal adhesion_Homo sapiens_hsa04510 | 1.65356195 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.64672357 |
| 20 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.63434860 |
| 21 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.60893707 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.59758230 |
| 23 | Proteasome_Homo sapiens_hsa03050 | 1.58539623 |
| 24 | Adherens junction_Homo sapiens_hsa04520 | 1.55667440 |
| 25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.55344265 |
| 26 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.53086861 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.51848608 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.48564037 |
| 29 | Amoebiasis_Homo sapiens_hsa05146 | 1.45783385 |
| 30 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.45081291 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.44746003 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.43835349 |
| 33 | Protein export_Homo sapiens_hsa03060 | 1.41674399 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36588276 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35561075 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33100434 |
| 37 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.32282651 |
| 38 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.31944221 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.31785422 |
| 40 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.30781403 |
| 41 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.23066410 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.20366899 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20361654 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.16604355 |
| 45 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.15991123 |
| 46 | Alcoholism_Homo sapiens_hsa05034 | 1.14083859 |
| 47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.12833002 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.11192025 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10010257 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08874609 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.08587978 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.08186894 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.07846880 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.06769438 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05772126 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.01935817 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01830750 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01376091 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.01300601 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00806619 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.98073711 |
| 62 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.96807514 |
| 63 | Long-term depression_Homo sapiens_hsa04730 | 0.95573064 |
| 64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.94943134 |
| 65 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.94290495 |
| 66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.93905698 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90391013 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.88729737 |
| 69 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87133873 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87090647 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.86978674 |
| 72 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.86267145 |
| 73 | Olfactory transduction_Homo sapiens_hsa04740 | 0.85131627 |
| 74 | Asthma_Homo sapiens_hsa05310 | 0.85130668 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82223419 |
| 76 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80099884 |
| 77 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80031339 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79340653 |
| 79 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.79263277 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78564723 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.78234552 |
| 82 | Allograft rejection_Homo sapiens_hsa05330 | 0.78163529 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78132135 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77201734 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77165627 |
| 86 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77118224 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76705053 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75795098 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74464597 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73541750 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72930647 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72737569 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71616554 |
| 94 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70992194 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70290494 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70243187 |
| 97 | Morphine addiction_Homo sapiens_hsa05032 | 0.69639081 |
| 98 | Circadian entrainment_Homo sapiens_hsa04713 | 0.68470689 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67866016 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67423538 |
| 101 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.67225702 |
| 102 | Melanoma_Homo sapiens_hsa05218 | 0.66872662 |
| 103 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.64786801 |
| 104 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.64677863 |
| 105 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64562919 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.63902236 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63152711 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62050318 |
| 109 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60299775 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.59414574 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58728397 |
| 112 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.57878575 |
| 113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57097696 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.55866562 |
| 115 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55296485 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54339922 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53967496 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51628541 |
| 119 | Carbon metabolism_Homo sapiens_hsa01200 | 0.49731052 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49125319 |
| 121 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46787928 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46671062 |
| 123 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46623663 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46258064 |
| 125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46103960 |
| 126 | Tight junction_Homo sapiens_hsa04530 | 0.45857950 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44357226 |
| 128 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44099329 |
| 129 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.43952384 |
| 130 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.42378141 |
| 131 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42274365 |
| 132 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.41999621 |
| 133 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41060050 |
| 134 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40877234 |
| 135 | Renin secretion_Homo sapiens_hsa04924 | 0.40794538 |
| 136 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39759559 |
| 137 | GABAergic synapse_Homo sapiens_hsa04727 | 0.39638687 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39506495 |
| 139 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39195213 |
| 140 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.38522668 |
| 141 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38197979 |
| 142 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37862707 |
| 143 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35521779 |
| 144 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35057302 |
| 145 | Gap junction_Homo sapiens_hsa04540 | 0.33934340 |
| 146 | Other glycan degradation_Homo sapiens_hsa00511 | 0.33447734 |
| 147 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.32767379 |
| 148 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28393168 |
| 149 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26707354 |
| 150 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.25680437 |
| 151 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.23808547 |
| 152 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.23648858 |

